As quoted in the press release:
The TSX Venture Exchange classifies issuers as “Tier 1” or “Tier 2” based on standards regarding historical financial performance, stage of development, and financial resources. Tier 1 is the highest tier of the TSX-V and is reserved for more advanced issuers with greater financial resources. Tier 1 issuers benefit from less stringent filing requirements.
“Our team has been working diligently to meet our stated cannabis production scaling objectives, progress our product innovation strategy, and advance a differentiating marketing plan. In conjunction with these efforts our valuation and financial resources have been increasing and we are pleased that our accomplishments have allowed us to attain a higher listing status on the TSX Venture Exchange,” said Chris Wagner, CEO of Emerald Health Therapeutics.